LUND, Sweden—Bioinformatics solutions provider Ludesi AB announced recently that Baltimore's Johns Hopkins Bayview Proteomics Center had chosen its 2-D gel image analysis system for its efforts to develop methods to investigate biological processes involved in human diseases. The agreement provides Ludesi with another high-profile entry into a 2-D gel market that is projected to surpass $700 million by 2010 according to a report by Frost & Sullivan.
Continue reading below...
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read More"Johns Hopkins Bayview Proteomics Center and Johns Hopkins School of Medicine is world-renowned for scientific excellence and front-end applied medical research," said Ola Forsstrom-Olsson, Ludesi CEO. "It is an honor to work with such successful and skilled scientists."
Although technical advances have pushed throughput for a variety of protein separation techniques, stalwart 2-D electrophoresis remains a major player in the proteomics marketplace. In part, this has been due to advances in gel imaging technologies that allow sample processing and data analysis to be largely automated.
